TRPM7 Gene Amyotrophic Lateral Sclerosis-Parkinsonism/Dementia Complex, Susceptibility to NGS Genetic Test
Short Name: TRPM7 ALS-Parkinsonism/Dementia Complex NGS Test
Also known as: TRPM7 Gene Sequencing, TRPM7 Susceptibility Genetic Test, ALS-Parkinsonism/Dementia Complex NGS Test, TRPM7 Neurodegenerative Susceptibility Test
TRPM7 Gene Amyotrophic Lateral Sclerosis-Parkinsonism/Dementia Complex, Susceptibility to NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses NGS Technology on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in 3 to 4 weeks after the sample is received by the laboratory.. Free home collection in 300+ cities across India.
🩺 Medically Reviewed By
Dr SULOCHANA HEMCHANDRA HOLLA
Consultant Medical Geneticist · Reg: 8532
Last reviewed: September 7, 2026
Overview
The purpose of this test is to identify clinically significant variants in the TRPM7 gene that may increase susceptibility to ALS-parkinsonism/dementia complex. NGS technology enables targeted analysis of the TRPM7 coding regions and splice sites, helping clinicians assess genetic risk and guide further evaluation of family members.
- Test Code
- 3893
- Price
- ₹20,000
- Sample Type
- Blood or Extracted DNA or One drop Blood on FTA Card
- Result Time
- 3 to 4 weeks after the sample is received by the laboratory.
- Fasting Required
- No
- Method
- NGS Technology
Sample Collection
No fasting is required. Please carry your clinical records, family history details and any referral notes provided by your doctor.
Method: Peripheral venipuncture or FTA card blood spot
Laboratory Analysis
A trained phlebotomist will collect venous blood from the arm. For FTA card collection, a few drops of blood will be placed on the FTA card and allowed to dry.
Report Delivery
No restrictions. You can resume normal activities immediately after sample collection.
Timeline: 3 to 4 weeks after the sample is received by the laboratory.
Patient Instructions
About This Test
Who Should Get This Test
The purpose of this test is to identify clinically significant variants in the TRPM7 gene that may increase susceptibility to ALS-parkinsonism/dementia complex. NGS technology enables targeted analysis of the TRPM7 coding regions and splice sites, helping clinicians assess genetic risk and guide further evaluation of family members.
How to Prepare
- No fasting required.
- A genetic counselling session is recommended before testing to draw a pedigree chart.
- Provide family history of neurological disorders.
- Use EDTA vacutainer for blood collection.
- For FTA card, ensure the marked spots are fully saturated and dried completely.
Doctor's Notes
Reviewed by Dr SULOCHANA HEMCHANDRA HOLLA — MBBS, MD (Medical Genetics) · Reg. No. 8532
"A positive or uncertain result should be interpreted in the context of clinical symptoms, family history and neurological examination. Genetic counselling is critical before and after testing."
Last medically reviewed: September 7, 2026
Test Parameters & Specifications
Sample Stability
- Hemolyzed or coagulated samples
- Improperly labelled samples
- Sample received after transport delay
- FTA card not fully dried
Understanding Your Results
Pathogenic / Likely Pathogenic variant
Indicates increased susceptibility and supports clinical correlation; genetic counselling recommended.
Variant of Uncertain Significance (VUS)
Cannot be classified as pathogenic or benign; family studies may help clarify the risk.
Benign / Likely Benign variant
Not considered a clinically significant risk factor for the condition.
No pathogenic variants detected
Does not exclude the condition; other genetic and non-genetic causes may be considered.
If you receive a pathogenic/likely pathogenic result or a VUS, please consult your referring neurologist or a clinical geneticist for personalised risk assessment.
Limitations
- ⚠NGS may not detect all types of mutations such as large rearrangements or repeat expansions
- ⚠TRPM7 gene variants may not be present in all individuals with ALS-parkinsonism/dementia complex
- ⚠A susceptibility variant is not diagnostic of disease
- ⚠Variant of uncertain significance (VUS) may require additional family studies
- ⚠This test does not exclude other genetic or environmental causes
Risks & Considerations
- ●Minor pain or bruising at the blood collection site
- ●No genetic test can predict disease onset with certainty
Interfering Factors
- ●Genomic DNA degradation
- ●Sample contamination with maternal DNA
- ●Incorrect sample labelling
- ●Incomplete clinical or family history limiting variant interpretation
Compare With Similar Tests
| Test | TRPM7 Gene Amyotrophic Lateral Sclerosis-Parkinsonism/Dementia Complex, Susceptibility to NGS Genetic Test | ||
|---|---|---|---|
| Comparison | TRPM7 Gene Amyotrophic Lateral Sclerosis-Parkinsonism/Dementia Complex, Susceptibility to NGS Genetic Test |
Frequently Asked Questions
What is the TRPM7 gene ALS-Parkinsonism/Dementia Complex NGS genetic test?
What sample is used for this test?
Is fasting required before this genetic test?
How much does the test cost?
How long does the report take?
Who should consider this genetic test?
Does this test diagnose ALS-parkinsonism/dementia complex?
What does a pathogenic result mean?
What is a variant of uncertain significance (VUS)?
Is home sample collection available?
Should I have genetic counselling before testing?
Will insurance cover this test?
Related Tests
Angelman Syndrome Test
₹10,000Duchenne / Becker Muscular Dystrophy (DMD / BMD) Gene Mutation Test
₹14,000Episodic Ataxia Type 1 Hotspot Test
₹11,500Episodic Ataxia Comprehensive Profile Hotspot Test
₹16,000Megalencephalic Leukoencephalopathy with Subcortical Cysts Van Der Knaap and Nalband MLC Gene Hotspot Mutation Test
₹7,500Analyzer 18 SMA 18 Test Panel
₹1,755Reference Laboratory Services
We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.
Your Data Privacy
Your medical data is protected under Indian law.
✓ Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.
✓ DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.
Book Your Test
Enter your details and we'll connect you within 15 minutes.
